Clinical Trial Details
| Trial ID: | L0641 |
| Source ID: | NCT00372489 |
| Associated Drug: | Peginesatide |
| Title: | Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD |
| Acronym: | |
| Status: | TERMINATED |
| Study Results: | YES |
| Results: | https://ClinicalTrials.gov/show/NCT00372489/results |
| Conditions: | Chronic Renal Failure|Chronic Kidney Disease|Anemia |
| Interventions: | DRUG: peginesatide |
| Outcome Measures: | Primary: Proportion of Participants With Mean Hemoglobin in the Target Range of 10.0-12.0 Grams Per Deciliter (g/dL) After Dosing Guideline Change, Up to 54 months | |
| Sponsor/Collaborators: | Sponsor: Affymax |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE2 |
| Enrollment: | 81 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2006-09 |
| Completion Date: | 2009-11 |
| Results First Posted: | 2012-05-28 |
| Last Update Posted: | 2012-06-29 |
| Locations: | Research Facility, Pine Bluff, Arkansas, 71603, United States|Research Facility, Mountain View, California, 94041, United States|Research Facility, Lauderdale Lakes, Florida, 33313, United States|Research Facility, Pembroke Pines, Florida, 33028, United States|Research Facility, Shreveport, Louisiana, 71101, United States|Research Facility, Detroit, Michigan, 48202, United States|Research Facility, Canton, Ohio, 44718, United States|Research Facility, Nashville, Tennessee, 37205, United States|Research Facility, San Antonio, Texas, 78215, United States |
| URL: | https://clinicaltrials.gov/show/NCT00372489 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|